E Lagrange, O Veran, G Besson. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/therapeutic useAutoantibodies/bloodAutoantibodies/immunologyBiomarkers/analysisBiomarkers/bloodBiopsyCarcinoma/complicationsCarcinoma/immunologyCystectomyG(M1) Ganglioside/immunologyGuillain-Barre Syndrome/immunologyGuillain-Barre Syndrome/physiopathologyHematuria/etiologyHumansMaleMiddle AgedNeural Conduction/immunologyParaneoplastic Syndromes, Nervous System/immunologyParaneoplastic Syndromes, Nervous System/physiopathologyPeripheral Nerves/immunologyPeripheral Nerves/pathologyPeripheral Nerves/physiopathologyRecurrenceTreatment OutcomeUrinary Bladder Neoplasms/complicationsUrinary Bladder Neoplasms/immunology
Substances: See more » Antineoplastic AgentsAutoantibodiesBiomarkersG(M1) Ganglioside
Year: 2007 PMID: 18028186 DOI: 10.1111/j.1468-1331.2007.01990.x
Source DB: PubMed Journal: Eur J Neurol ISSN: 1351-5101 Impact factor: 6.089